The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
Titel:
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
Auteur:
Wiesmann, Frank Vachta, Jan Ehret, Robert Walter, Hauke Kaiser, Rolf Stürmer, Martin Tappe, André Däumer, Martin Berg, Thomas Naeth, Gudrun Braun, Patrick Knechten, Heribert